Bardoxolone

CDDO is a synthetic oleanane triterpenoid that blocks the cellular synthesis of inducible nitric oxide synthase and inducible COX-2 in INF-γ-activated mouse macrophages with an IC50 value of 0.4 nM. By suppressing reactive oxygen and nitrogen species (ROS/RNS) formation, it promotes the cellular control of ROS/RNS levels that would lead to DNA damage associated with tumorigenesis. In various Y cell lines, CDDO has been shown to specifically inhibit proliferation and induce apoptosis. Mechanism studies revealed that CDDO is a ligand for peroxisome proliferator-activated receptor γ, and also that it induces genes regulated by Nrf2, including heme oxygenase-1 and eotaxin-1, which play a role in antioxidant response element signaling activity.

Price Not Available 5 mg Bardoxolone Supplier Page
Catalog Number T2915
Alternative Name(s) CDDO , RTA 401
Research Area Immunology/Inflammation|||Others
Molecular Formula C31H41NO4
CAS# 218600-44-3
Purity 97.90%
SMILES C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C1[C@]2(CC[C@@H]2[C@@]1(C=C(C(=O)C2(C)C)C#N)C)C)(C)C)C(=O)O
Size 5 mg
Supplier Page https://www.targetmol.com/compound/Bardoxolone
Additional Information https://www.targetmol.com/datasheet/T2915